pentetic acid has been researched along with dysprosium in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.26) | 18.7374 |
1990's | 38 (80.85) | 18.2507 |
2000's | 7 (14.89) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barker, PB; Bryan, RN; Conturo, TE; Mathews, VP; Monsein, LH | 1 |
Kiihne, S; Weisskoff, RM | 1 |
Bauer, WR; Schulten, K | 1 |
Higgins, CB; Saeed, M; Wendland, MF | 3 |
Asgari, H; Kucharczyk, J; Mintorovitch, J; Moseley, M; Rocklage, S; Vexler, Z; Watson, A | 1 |
Asgari, HS; Derugin, N; Kucharczyk, J; Mintorovitch, J; Moseley, ME; Rocklage, S; Vexler, Z | 1 |
Higgins, CB; Saeed, M; Wendland, M | 1 |
Asgari, HS; Kucharczyk, J; Mintorovitch, J; Moseley, ME; Sevick, R; Wendland, MF; White, DL | 1 |
Kucharczyk, J; Moseley, ME; Norman, D; Quay, SC; Rocklage, SM | 1 |
Brown, MA; Drayer, BP; Ribeiro, AA; Spicer, LD; Stenzel, TT | 1 |
Higgins, CB; Moseley, ME; Quay, SC; Rocklage, SM; Saeed, M; Tomei, E; Wendland, MF; Wolfe, C | 1 |
Nilsson, S | 1 |
Ericsson, A; Hemmingsson, A; Martinussen, HJ; Nilsson, S; Oksendal, AN; Waldenström, A; Wikström, G; Wikström, M | 1 |
Ericsson, A; Hemmingsson, A; Nilsson, S; Oksendal, A; Waldenström, A; Wikström, G; Wikström, M | 3 |
Di Bartolo, N; Hetherington, EL; Knapp, FF; Lambrecht, RM; Mirzadeh, S; Smith, SV | 1 |
Runge, VM; Wells, JW | 1 |
Dommisse, R; Lanens, D; Oksendal, A; Spanoghe, M; Van Audekerke, J; Van der Linden, A | 1 |
Bach-Gansmo, T; Ericsson, A; Hemmingsson, A; Niklasson, F | 1 |
Godtliebsen, F; Haraldseth, O; Jones, RA; Lindboe, CF; Müller, TB; Sebastiani, G; Unsgård, G | 1 |
Boxerman, JL; Rosen, BR; Weisskoff, RM; Zuo, CS | 1 |
Constable, RT; Gore, JC; Kennan, RP; McCarthy, G; Puce, A | 1 |
Haraldseth, O; Jones, RA; Müller, TB; Oksendal, AN; Rinck, PA | 1 |
de Crespigny, AJ; Kucharcyzk, J; Moseley, ME; Roberts, TP | 1 |
Chu, WJ; Elgavish, GA | 1 |
Allen, PS; Martin, WR; Ye, FQ | 1 |
Bauer, M; Krause, W; Muschick, P; Press, WR; Schuhmann-Giampieri, G | 1 |
Delos, M; Demeure, R; Goudemant, JF; Jamart, J; Maldague, B; Oksendal, A; Pringot, J; Thiran, JP; Van Beers, BE | 1 |
Dadachova, E; Hetherington, EL; Knapp, FF; Mirzadeh, S; Smith, SV | 1 |
Derugin, N; Geschwind, JF; Higgins, CB; Lauerma, K; Saeed, M; Wendland, MF | 1 |
Beache, GM; Brady, TJ; Campbell, TA; Chesler, DA; Gewirtz, H; Kantor, HL; Kulke, SF; Niemi, P; Rosen, BR; Weisskoff, RM | 1 |
Koenig, SH | 1 |
Brechbiel, MW; Brooks, RA; Bulte, JW; Frank, JA; Holla, M; Vymazal, J; Wu, C | 1 |
Colet, JM; Fahlvik, AK; Fossheim, SL; Kellar, KE; Klaveness, J; Mansson, S; Rongved, P | 1 |
Fossheim, SL; Kellar, KE; Spiller, M | 1 |
Arteaga, C; Canet, E; Forrat, R; Hadour, G; Oksendal, A; Revel, D; Zhao, S | 1 |
Higgins, CB; Lund, G; Saeed, M; Wendland, MF | 1 |
Colby, AL; Frederique, DE; Miles, RD; Pond, BV; Roan, MA; Troughton, JS; Wenzel, TJ; Zomlefer, K | 1 |
Gore, JC; Johnson, KM; Kennan, RP; Tao, JZ | 2 |
Bach-Gansmo, T; Buzelin, MF; Dupas, B; Karam, G; Meflah, K; Vasse, N | 1 |
Mattrey, RF; Vera, DR | 1 |
Botteman, F; Laurent, S; Muller, RN; Sherry, AD; Vander Elst, L; Zhang, S | 1 |
Arteaga de Murphy, C; Ferro-Flores, G; Jiménez-Varela, R; Meléndez-Alafort, L; Monroy-Guzmán, F; Pedraza-López, M; Tendilla, JI | 1 |
2 review(s) available for pentetic acid and dysprosium
Article | Year |
---|---|
Update: safety, new applications, new MR agents.
Topics: Animals; Brain; Brain Diseases; Contrast Media; Dysprosium; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1995 |
Contrast-enhanced MRI for quantification of myocardial viability.
Topics: Animals; Contrast Media; Dysprosium; Edetic Acid; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Manganese; Myocardial Ischemia; Myocardial Stunning; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1999 |
45 other study(ies) available for pentetic acid and dysprosium
Article | Year |
---|---|
MR imaging of cerebral perfusion by phase-angle reconstruction of bolus paramagnetic-induced frequency shifts.
Topics: Animals; Brain; Brain Ischemia; Capillaries; Cerebrovascular Circulation; Contrast Media; Dysprosium; Electron Spin Resonance Spectroscopy; Gadolinium; Gadolinium DTPA; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Microcirculation; Models, Biological; Models, Chemical; Models, Structural; Organometallic Compounds; Papio; Pentetic Acid; Putamen | 1992 |
MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood.
Topics: Contrast Media; Dextrans; Dysprosium; Erythrocytes; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; In Vitro Techniques; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Pentetic Acid | 1992 |
Theory of contrast agents in magnetic resonance imaging: coupling of spin relaxation and transport.
Topics: Contrast Media; Dysprosium; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Iron; Kupffer Cells; Magnetic Resonance Imaging; Models, Biological; Models, Theoretical; Organometallic Compounds; Oxides; Pentetic Acid | 1992 |
Strategies for differential enhancement of myocardial ischemia using echoplanar imaging.
Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Myocardium; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |
Characterization of reperfused myocardial infarctions with T1-enhancing and magnetic susceptibility-enhancing contrast media.
Topics: Animals; Contrast Media; Diagnosis, Differential; Drug Evaluation, Preclinical; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |
Magnetic resonance imaging of brain perfusion using the nonionic contrast agents Dy-DTPA-BMA and Gd-DTPA-BMA.
Topics: Animals; Brain; Cats; Contrast Media; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Time Factors | 1991 |
Comparison of Gd- and Dy-chelates for T2 contrast-enhanced imaging.
Topics: Animals; Brain; Brain Ischemia; Cats; Contrast Media; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1991 |
Contrast enhancement for the myocardium.
Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Myocardium; Organometallic Compounds; Pentetic Acid | 1991 |
Ultrafast magnetic resonance imaging: diffusion and perfusion.
Topics: Animals; Brain Ischemia; Cats; Cerebral Arteries; Cerebrovascular Disorders; Contrast Media; Diffusion; Dysprosium; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Perfusion; Time Factors | 1991 |
Early detection of perfusion deficits caused by regional cerebral ischemia in cats. T2-weighted magnetic susceptibility MRI using a nonionic dysprosium contrast agent.
Topics: Animals; Brain Ischemia; Cats; Contrast Media; Dysprosium; Magnetic Resonance Imaging; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Time Factors | 1990 |
Magnetic resonance contrast media for myocardial imaging.
Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats | 1990 |
NMR studies of combined lanthanide shift and relaxation agents for differential characterization of 23Na in a two-compartment model system.
Topics: Animals; Dysprosium; Edetic Acid; Gadolinium; Humans; Ion Channels; Magnetic Resonance Spectroscopy; Metals, Rare Earth; Pentetic Acid; Polyphosphates; Sodium | 1986 |
Demarcation of myocardial ischemia: magnetic susceptibility effect of contrast medium in MR imaging.
Topics: Animals; Blood Pressure; Contrast Media; Coronary Disease; Dysprosium; Heart Rate; Magnetic Resonance Imaging; Muscles; Myocardium; Organometallic Compounds; Pentetic Acid; Radionuclide Imaging; Rats | 1989 |
MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
Topics: Analysis of Variance; Animals; Contrast Media; Diagnosis, Differential; Dysprosium; Evaluation Studies as Topic; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Swine; Time Factors; Tissue Survival | 1995 |
Dy-DTPA-BMA as an indicator of tissue viability in MR imaging. An experimental study in the pig.
Topics: Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Dysprosium; Female; Magnetic Resonance Imaging; Male; Myocardial Infarction; Myocardium; Organometallic Compounds; Pentetic Acid; Swine; Time Factors; Tissue Survival | 1995 |
MR imaging of double-contrast enhanced porcine myocardial infarction. Correlation with microdialysis.
Topics: Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; Drug Interactions; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Microdialysis; Myocardial Infarction; Myocardium; Organometallic Compounds; Pentetic Acid; Swine; Time Factors | 1995 |
[166Dy]dysprosium/[166Ho]holmium in vivo generator.
Topics: Animals; Bone and Bones; Bone Marrow; Dysprosium; Holmium; Humans; Kinetics; Mice; Mice, Inbred BALB C; Organometallic Compounds; Pentetic Acid; Radioisotopes; Serum Albumin; Tissue Distribution | 1995 |
Complementary use of T2-weighted and postcontrast T1- and T2*-weighted imaging to distinguish sites of reversible and irreversible brain damage in focal ischemic lesions in the rat brain.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Contrast Media; Dysprosium; Gadolinium; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Wistar; Time Factors | 1995 |
Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging.
Topics: Cell Membrane; Contrast Media; Dysprosium; Erythrocytes; Gadolinium; Gadolinium DTPA; Hematocrit; Humans; Image Enhancement; In Vitro Techniques; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1995 |
Combined perfusion and diffusion-weighted magnetic resonance imaging in a rat model of reversible middle cerebral artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Cerebrovascular Circulation; Contrast Media; Diffusion; Disease Models, Animal; Dysprosium; Frontal Lobe; Image Enhancement; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Organometallic Compounds; Parietal Lobe; Pentetic Acid; Perfusion; Putamen; Rats; Rats, Wistar; Reperfusion | 1995 |
Microscopic susceptibility variation and transverse relaxation: theory and experiment.
Topics: Animals; Computer Simulation; Contrast Media; Diffusion; Dysprosium; Humans; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Microspheres; Models, Biological; Models, Chemical; Models, Theoretical; Monte Carlo Method; Organometallic Compounds; Particle Size; Pentetic Acid; Polystyrenes; Protons | 1994 |
Functional NMR imaging using fast spin echo at 1.5 T.
Topics: Body Water; Brain; Diffusion; Dysprosium; Hemoglobins; Humans; Image Enhancement; Magnetic Resonance Imaging; Microcirculation; Models, Structural; Models, Theoretical; Organometallic Compounds; Oxyhemoglobins; Particle Size; Pentetic Acid; Photic Stimulation; Polystyrenes; Regional Blood Flow; Visual Cortex; Water | 1994 |
K-space substitution: a novel dynamic imaging technique.
Topics: Animals; Brain; Brain Ischemia; Contrast Media; Dysprosium; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Rats | 1993 |
Improved sensitivity to magnetic susceptibility contrast.
Topics: Animals; Brain; Brain Ischemia; Cats; Contrast Media; Dysprosium; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Subtraction Technique | 1993 |
Myocardial cell death in reperfused and nonreperfused myocardial infarctions. MR imaging with dysprosioum-DTPA-BMA in the pig.
Topics: Animals; Cell Death; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Dysprosium; Female; Magnetic Resonance Angiography; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Swine | 1996 |
Double-contrast MR imaging of reperfused porcine myocardial infarction. An experimental study using Gd-DTAA and Dy-DTPA-BMA.
Topics: Animals; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Angiography; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Swine | 1996 |
Gadolinium and dysprosium chelates of DTPA-amide-dextran: synthesis, 1H NMR relaxivity, and induced 23Na NMR shift.
Topics: Amides; Chelating Agents; Dextrans; Dysprosium; Gadolinium; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pentetic Acid; Protons; Sodium Isotopes | 1995 |
Estimation of brain iron in vivo by means of the interecho time dependence of image contrast.
Topics: Adult; Body Water; Brain; Brain Diseases; Confidence Intervals; Contrast Media; Dysprosium; Frontal Lobe; Gels; Globus Pallidus; Humans; Image Enhancement; Iron; Magnetic Resonance Imaging; Microspheres; Neuroglia; Organometallic Compounds; Pentetic Acid; Phantoms, Imaging; Putamen; Reproducibility of Results; Thalamus | 1996 |
Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography.
Topics: Animals; Biological Products; Bismuth; Bone and Bones; Cerium; Chelating Agents; Chemical Phenomena; Chemistry, Physical; Contrast Media; Dysprosium; Erythrocytes; Humans; Lanthanum; Lead; Liver; Lutetium; Minerals; Organometallic Compounds; Osmolar Concentration; Partial Thromboplastin Time; Pentetic Acid; Phantoms, Imaging; Praseodymium; Protein Binding; Rabbits; Radiographic Image Enhancement; Rats; Tissue Distribution; Tomography, X-Ray Computed; Viscosity; Ytterbium | 1996 |
Detection of reperfused ischemia of the rat intestine: value of magnetic resonance imaging with small-molecular-weight dysprosium and gadolinium chelates.
Topics: Animals; Contrast Media; Dysprosium; Gadolinium; Gadolinium DTPA; Image Enhancement; Injections, Intravenous; Intestines; Ischemia; Magnetic Resonance Imaging; Male; Molecular Weight; Organometallic Compounds; Pentetic Acid; Rats; Rats, Wistar | 1997 |
Radiolabeling antibodies with holmium-166.
Topics: Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Dysprosium; Holmium; Hydroxybutyrates; Immunoconjugates; Isotope Labeling; Pentetic Acid; Radioisotopes | 1997 |
AUR Memorial Award. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging.
Topics: Animals; Awards and Prizes; Cell Death; Contrast Media; Drug Evaluation, Preclinical; Dysprosium; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley | 1994 |
Imaging perfusion deficits in ischemic heart disease with susceptibility-enhanced T2-weighted MRI: preliminary human studies.
Topics: Adult; Aged; Artifacts; Contrast Media; Dysprosium; Feasibility Studies; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pentetic Acid; Sensitivity and Specificity | 1998 |
Solvent relaxation by uniformly magnetized solute spheres. The classical-quantal connection.
Topics: Contrast Media; Dysprosium; Humans; Magnetic Resonance Imaging; Microspheres; Monte Carlo Method; Organometallic Compounds; Particle Size; Pentetic Acid; Polystyrenes; Water | 1998 |
Dysprosium-DOTA-PAMAM dendrimers as macromolecular T2 contrast agents. Preparation and relaxometry.
Topics: Contrast Media; Dysprosium; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1998 |
Investigation of lanthanide-based starch particles as a model system for liver contrast agents.
Topics: Animals; Contrast Media; Dysprosium; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Male; Metals, Rare Earth; Organometallic Compounds; Particle Size; Pentetic Acid; Rats; Rats, Wistar; Spectrophotometry, Atomic; Tissue Distribution | 1999 |
NMRD investigation of DyDTPA- and GdDTPA-labeled starch particles. Selection of a suitable suspension medium and influence of the starch matrix on relaxivity.
Topics: Contrast Media; Dysprosium; Gadolinium DTPA; Humans; Organometallic Compounds; Pentetic Acid; Polyethylene Glycols; Starch | 1999 |
Myocardial "low reflow" assessed by Dy-DTPA-BMA-enhanced first-pass MR imaging in a dog model.
Topics: Animals; Contrast Media; Coronary Circulation; Dogs; Dysprosium; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Organometallic Compounds; Pentetic Acid | 1999 |
Dysprosium(III)-diethylenetriaminepentaacetate complexes of aminocyclodextrins as chiral NMR shift reagents.
Topics: Cyclodextrins; Dysprosium; Indicators and Reagents; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Pentetic Acid; Stereoisomerism | 2000 |
Intravascular susceptibility agent effects on tissue transverse relaxation rates in vivo.
Topics: Acetylcysteine; Analysis of Variance; Animals; Contrast Media; Dose-Response Relationship, Drug; Dysprosium; Erythrocytes; Female; Magnetic Resonance Angiography; Microcirculation; Pentetic Acid; Rats; Rats, Sprague-Dawley; Spectrophotometry, Atomic | 2000 |
Contrast-enhanced MR imaging of experimental acute tubular necrosis.
Topics: Animals; Contrast Media; Diagnosis, Differential; Drug Combinations; Dysprosium; Gadolinium DTPA; Injections, Intravenous; Kidney Medulla; Kidney Tubular Necrosis, Acute; Kidney Tubules; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred BN | 2001 |
Dysprosium-bearing red cells as potential transverse relaxation agents for MRI.
Topics: Animals; Chelating Agents; Dysprosium; Erythrocytes; Half-Life; Humans; Magnetic Resonance Imaging; Pentetic Acid; Rats | 2001 |
A molecular CT blood pool contrast agent.
Topics: Animals; Contrast Media; Dysprosium; Liver Neoplasms, Experimental; Macrophage Activation; Molecular Weight; Organometallic Compounds; Pentetic Acid; Rabbits; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2002 |
Dy-complexes as high field T2 contrast agents: influence of water exchange rates.
Topics: Body Water; Contrast Media; Dysprosium; Humans; Ligands; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 2002 |
Labeling of biotin with [166Dy]Dy/166Ho as a stable in vivo generator system.
Topics: Animals; Biotin; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Drug Stability; Dysprosium; Female; Holmium; Injections, Intravenous; Isotope Labeling; Mice; Mice, Inbred BALB C; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Tissue Distribution | 2003 |